Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of SARS-CoV-2 infectivity
L. Diomede, S. Baroni, A. De Luigi, A. Piotti, J. Lucchetti, C. Fracasso, L. Russo, V. Bonaldo, N. Panini, F. Filippini, F. Fiordaliso, A. Corbelli, M. Beeg, M. Pizzato, F. Caccuri, , M. Salmona
This paper tests doxycycline's effect on SARS-CoV-2 infection using pseudovirus and clinical strains, finding it inhibits pseudovirus transduction but not actual SARS-CoV-2 entry and replication.
bioRxiv · Jul 30, 2021Pharmacology & Toxicology